Literature DB >> 16113774

Sample selection for microarray gene expression studies.

D Repsilber1, L Fink, M Jacobsen, O Bläsing, A Ziegler.   

Abstract

OBJECTIVES: The choice of biomedical samples for microarray gene expression studies is decisive for both validity and interpretability of results. We present a consistent, comprehensive framework to deal with the typical selection problems in microarray studies.
METHODS: Microarray studies are designed either as case-control studies or as comparisons of parallel groups from cohort studies, since high levels of random variation in the experimental approach thwart absolute measurements of gene expression levels. Validity and results of gene expression studies heavily rely on the appropriate choice of these study groups. Therefore, the so-called principles of comparability, which are well known from both clinical and epidemiological studies, need to be applied to microarray experiments.
RESULTS: The principles of comparability are the study-base principle, the principle of deconfounding and the principle of comparable accuracy in measurements. We explain each of these principles, show how they apply to microarray experiments, and illustrate them with examples. The examples are chosen as to represent typical stumbling blocks of microarray experimental design, and to exemplify the benefits of implementing the principles of comparability in the setting of microarray experiments.
CONCLUSIONS: Microarray studies are closely related to classical study designs and therefore have to obey the same principles of comparability as these. Their validity should not be compromised by selection, confounding or information bias. The so-called study-base principle, calling for comparability and thorough definition of the compared cell populations, is the key principle for the choice of biomedical samples and controls in microarray studies.

Mesh:

Year:  2005        PMID: 16113774

Source DB:  PubMed          Journal:  Methods Inf Med        ISSN: 0026-1270            Impact factor:   2.176


  4 in total

1.  Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins.

Authors:  Iain C Macaulay; Marloes R Tijssen; Daphne C Thijssen-Timmer; Arief Gusnanto; Michael Steward; Philippa Burns; Cordelia F Langford; Peter D Ellis; Frank Dudbridge; Jaap-Jan Zwaginga; Nicholas A Watkins; C Ellen van der Schoot; Willem H Ouwehand
Journal:  Blood       Date:  2006-12-27       Impact factor: 22.113

2.  Analyzing illumina gene expression microarray data from different tissues: methodological aspects of data analysis in the metaxpress consortium.

Authors:  Claudia Schurmann; Katharina Heim; Arne Schillert; Stefan Blankenberg; Maren Carstensen; Marcus Dörr; Karlhans Endlich; Stephan B Felix; Christian Gieger; Harald Grallert; Christian Herder; Wolfgang Hoffmann; Georg Homuth; Thomas Illig; Jochen Kruppa; Thomas Meitinger; Christian Müller; Matthias Nauck; Annette Peters; Rainer Rettig; Michael Roden; Konstantin Strauch; Uwe Völker; Henry Völzke; Simone Wahl; Henri Wallaschofski; Philipp S Wild; Tanja Zeller; Alexander Teumer; Holger Prokisch; Andreas Ziegler
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

3.  Biomarker discovery in heterogeneous tissue samples -taking the in-silico deconfounding approach.

Authors:  Dirk Repsilber; Sabine Kern; Anna Telaar; Gerhard Walzl; Gillian F Black; Joachim Selbig; Shreemanta K Parida; Stefan H E Kaufmann; Marc Jacobsen
Journal:  BMC Bioinformatics       Date:  2010-01-14       Impact factor: 3.169

4.  Revisiting adverse effects of cross-hybridization in Affymetrix gene expression data: do they matter for correlation analysis?

Authors:  Lev Klebanov; Linlin Chen; Andrei Yakovlev
Journal:  Biol Direct       Date:  2007-11-07       Impact factor: 4.540

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.